Article Information
History
- March 31, 2021.
Article Versions
- Version 1 (September 1, 2020 - 17:04).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Keith A. Misquitta1,2,
- Amy Miles1,
- Thomas D. Prevot1,4,
- Jaime K. Knoch1,2,
- Corey Fee1,2,
- Dwight F. Newton1,2,
- Jacob Ellegood3,
- Jason P. Lerch3,5,6,
- Etienne Sibille1,2,4,
- Yuliya S. Nikolova1,4 and
- Mounira Banasr1,2,4,*
- 1Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada
- 2Departments of Pharmacology and Toxicology, University of Toronto, Toronto, Canada
- 3Mouse Imaging Centre (MICe), Hospital for Sick Children, Toronto, Canada
- 4Department of Psychiatry, University of Toronto, Toronto, Canada
- 5Wellcome Centre for Integrative Neuroimaging, FMRIB, Nuffield Department of Clinical Neuroscience, The University of Oxford, Oxford, UK
- 6Department of Medical Biophyics, The University of Toronto, Toronto, Canada
- ↵*Corresponding author: Mounira Banasr, PhD, CAMH, 250 College Street, Toronto, ON, M5T1R8, Canada, Tel: 416-557-8302, Email: mounira.banasr{at}camh.ca
Contributions: Chronic restraint stress and Behavioral testing (KAM, TDP, CF), MRI and analysis (KAM, JKK, JE, JPL, DFN), Structural covariance analysis (AM,YN), Immunohistochemistry (KAM), study design, interpretation of the results and writing of the manuscript (KAM, ES, MB).